ERBB2 and breast carcinoma: Poly (β-L-malic acid) and polyethylene glycol (PEG)–antibody conjugates by covalently incorporating anti-HER2/neu peptide (AHNP) (trastuzumab-mimetic 12-merpeptide) for the treatment breast cancer [26].